IFP Advisors’s Avidity Biosciences RNAM Stock Holding History

IFP Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,977	Closed	-$287K	–	5135
2025 Q4	$287K	Sell	3,977 -14	-0.4%	-$904	0.01%	1189
2025 Q3	$174K	Buy	3,991 +986	+33%	+$39.9K	﹤0.01%	1356
2025 Q2	$98.3K	Sell	3,005 -232	-7%	-$6.92K	﹤0.01%	1650
2025 Q1	$95.7K	Buy	3,237 +1,787	+123%	+$55.7K	﹤0.01%	1552
2024 Q4	$42.3K	Sell	1,450 -55	-4%	-$2.3K	﹤0.01%	1905
2024 Q3	$69.1K	Buy	+1,505	New	+$65.3K	﹤0.01%	1572
2023 Q3	–	Sell	-4	Closed	-$44	–	3508
2023 Q2	$44	Buy	+4	New	+$50	﹤0.01%	3396

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

IFP Advisors's RNAM Position: Q1 2026 in Review

IFP Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,977 shares — an estimated $287K sold.

IFP Advisors first reported a position in RNAM in Q2 2023 and held it in 7 quarters. The position peaked at $287K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

IFP Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
IFP Advisors sold 3,977 Avidity Biosciences shares in Q1 2026, an estimated $287K.
IFP Advisors first reported a position in Avidity Biosciences in Q2 2023 and held it in 7 quarters.
IFP Advisors's Avidity Biosciences position peaked at $287K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.